21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Poly(ADP-ribose) polymerase 1 regulates nuclear reprogramming and promotes iPSC generation without c-Myc

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Parp1 can replace c-Myc to promote induced pluripotent stem cell (iPSC) generation.

          Abstract

          Poly(ADP-ribose) polymerase 1 (Parp1) catalyzes poly(ADP-ribosylation) (PARylation) and induces replication networks involved in multiple nuclear events. Using mass spectrometry and Western blotting, Parp1 and PARylation activity were intensively detected in induced pluripotent stem cells (iPSCs) and embryonic stem cells, but they were lower in mouse embryonic fibroblasts (MEFs) and differentiated cells. We show that knockdown of Parp1 and pharmacological inhibition of PARylation both reduced the efficiency of iPSC generation induced by Oct4/Sox2/Klf4/c-Myc. Furthermore, Parp1 is able to replace Klf4 or c-Myc to enhance the efficiency of iPSC generation. In addition, mouse iPSCs generated from Oct4/Sox2/Parp1-overexpressing MEFs formed chimeric offspring. Notably, the endogenous Parp1 and PARylation activity was enhanced by overexpression of c-Myc and repressed by c-Myc knockdown. A chromatin immunoprecipitation assay revealed a direct interaction of c-Myc with the Parp1 promoter. PAR-resin pulldown, followed by proteomic analysis, demonstrated high levels of PARylated Chd1L, DNA ligase III, SSrp1, Xrcc-6/Ku70, and Parp2 in pluripotent cells, which decreased during the differentiation process. These data show that the activation of Parp1, partly regulated by endogenous c-Myc, effectively promotes iPSC production and helps to maintain a pluripotent state by posttranslationally modulating protein PARylation.

          Related collections

          Author and article information

          Journal
          J Exp Med
          J. Exp. Med
          jem
          The Journal of Experimental Medicine
          The Rockefeller University Press
          0022-1007
          1540-9538
          14 January 2013
          : 210
          : 1
          : 85-98
          Affiliations
          [1 ]Genomic Center & Cancer Center , [2 ]Aging and Health Research Center , [3 ]Institute of Oral biology , [4 ]Institute of Pharmacology , and [5 ]Institute of Clinical Medicine, School of Medicine, National Yang-Ming University, Taipei, 112 Taiwan
          [6 ]Graduate Institute of Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, 40402 Taiwan
          [7 ]Department of Biotechnology, Asia University, Taichung, 413 Taiwan
          [8 ]Center for Geriatrics and Gerontology , [9 ]Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, 11217 Taiwan
          Author notes
          CORRESPONDENCE Shih-Hwa Chiou: shchiou@ 123456vghtpe.gov.tw

          B.-H. Jiang, Y.-L. Yu, W.-C. Chang, and Y. Chien contributed equally to this paper.

          Article
          20121044
          10.1084/jem.20121044
          3549716
          23277454
          fcde4c67-2fe9-4bc6-9a76-148f263eafec
          © 2013 Chiou et al.

          This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

          History
          : 16 May 2012
          : 5 December 2012
          Categories
          Article

          Medicine
          Medicine

          Comments

          Comment on this article